Literature DB >> 24871143

Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases.

Evan M Thomas1, Richard A Popple, Xingen Wu, Grant M Clark, James M Markert, Barton L Guthrie, Yu Yuan, Michael C Dobelbower, Sharon A Spencer, John B Fiveash.   

Abstract

BACKGROUND: Volumetric modulated arc therapy (VMAT) has been shown to be feasible for radiosurgical treatment of multiple cranial lesions with a single isocenter.
OBJECTIVE: To investigate whether equivalent radiosurgical plan quality and reduced delivery time could be achieved in VMAT for patients with multiple intracranial targets previously treated with Gamma Knife (GK) radiosurgery.
METHODS: We identified 28 GK treatments of multiple metastases. These were replanned for multiarc and single-arc, single-isocenter VMAT (RapidArc) in Eclipse. The prescription for all targets was standardized to 18 Gy. Each plan was normalized for 100% prescription dose to 99% to 100% of target volume. Plan quality was analyzed by target conformity (Radiation Therapy Oncology Group and Paddick conformity indices [CIs]), dose falloff (area under the dose-volume histogram curve), as well as the V4.5, V9, V12, and V18 isodose volumes. Other end points included beam-on and treatment time.
RESULTS: Compared with GK, multiarc VMAT improved median plan conformity (CIVMAT = 1.14, CIGK = 1.65; P < .001) with no significant difference in median dose falloff (P = .269), 12 Gy isodose volume (P = .500), or low isodose spill (P = .49). Multiarc VMAT plans were associated with markedly reduced treatment time. A predictive model of the 12 Gy isodose volume as a function of tumor number and volume was also developed.
CONCLUSION: For multiple target stereotactic radiosurgery, 4-arc VMAT produced clinically equivalent conformity, dose falloff, 12 Gy isodose volume, and low isodose spill, and reduced treatment time compared with GK. Because of its similar plan quality and increased delivery efficiency, single-isocenter VMAT radiosurgery may constitute an attractive alternative to multi-isocenter radiosurgery for some patients.

Entities:  

Mesh:

Year:  2014        PMID: 24871143      PMCID: PMC4203364          DOI: 10.1227/NEU.0000000000000448

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  17 in total

Review 1.  Adjuvant treatment of brain metastases.

Authors:  F Lohr; A Pirzkall; H Hof; K Fleckenstein; J Debus
Journal:  Semin Surg Oncol       Date:  2001 Jan-Feb

2.  Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group.

Authors:  J C Flickinger; D Kondziolka; L D Lunsford; A Kassam; L K Phuong; R Liscak; B Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

3.  Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization.

Authors:  M Zaider; H I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-05-01       Impact factor: 7.038

4.  X-ray leakage considerations for IMRT.

Authors:  P O Williams; A R Hounsell
Journal:  Br J Radiol       Date:  2001-01       Impact factor: 3.039

5.  A method for optimizing LINAC treatment geometry for volumetric modulated arc therapy of multiple brain metastases.

Authors:  Jun Kang; Eric C Ford; Koren Smith; John Wong; Todd R McNutt
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

6.  Use of hybrid shots in planning Perfexion Gamma Knife treatments for lesions close to critical structures.

Authors:  Paula L Petti; David A Larson; Sandeep Kunwar
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

7.  Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.

Authors:  S Wachter; N Gerstner; G Goldner; R Pötzi; A Wambersie; R Pötter
Journal:  Radiother Oncol       Date:  2001-04       Impact factor: 6.280

8.  Radiosurgery with the world's first fully robotized Leksell Gamma Knife PerfeXion in clinical use: a 200-patient prospective, randomized, controlled comparison with the Gamma Knife 4C.

Authors:  Jean Régis; Manabu Tamura; Cécile Guillot; Shoji Yomo; Xavier Muraciolle; Mariko Nagaje; Yasser Arka; Denis Porcheron
Journal:  Neurosurgery       Date:  2009-02       Impact factor: 4.654

9.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

10.  Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis.

Authors:  Ashesh B Jani; Christopher M Hand; Charles A Pelizzari; John C Roeske; Lani Krauz; Srinivasan Vijayakumar
Journal:  BMC Cancer       Date:  2003-05-13       Impact factor: 4.430

View more
  71 in total

1.  Investigation of two linear accelerator head designs for treating brain metastases with hypofractionated volumetric-modulated arc radiotherapy.

Authors:  Mark Ruschin; Arjun Sahgal; Sara Iradji; Hany Soliman; Claudia Leavens; Young Lee
Journal:  Br J Radiol       Date:  2016-04-13       Impact factor: 3.039

2.  Single-Isocenter Frameless Volumetric Modulated Arc Radiosurgery for Multiple Intracranial Metastases.

Authors:  Steven K M Lau; Kaveh Zakeri; Xiao Zhao; Ruben Carmona; Erik Knipprath; Daniel R Simpson; Sameer K Nath; Gwe-Ya Kim; Parag Sanghvi; Jona A Hattangadi-Gluth; Clark C Chen; Kevin T Murphy
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

3.  Intrafraction motion during frameless radiosurgery using Varian HyperArcTM and BrainLab ElementsTM immobilization systems.

Authors:  Amish P Shah; Dylan T Meeks; Twyla R Willoughby; Naren Ramakrishna; Christopher J Warner; Cameron W Swanick; Patrick Kelly; Sanford L Meeks
Journal:  J Radiosurg SBRT       Date:  2020

4.  Dosimetric comparison of intracranial metastasis treatment using two radiosurgery systems: TrueBeam STx with VMAT and Gamma Knife Model 4C.

Authors:  Vance Keeling; Ozer Algan; Salahuddin Ahmad; Sabbir Hossain
Journal:  J Radiosurg SBRT       Date:  2016

5.  Radiosurgery of brain metastases - How many is too many?

Authors:  John B Fiveash; Lauren Kropp
Journal:  J Radiosurg SBRT       Date:  2016

6.  Evaluation of multiple factors affecting normal brain dose in single-isocenter multiple target radiosurgery.

Authors:  Yu Yuan; Evan M Thomas; Grant A Clark; James M Markert; John B Fiveash; Richard A Popple
Journal:  J Radiosurg SBRT       Date:  2018

7.  Evaluation of a magnetic resonance guided linear accelerator for stereotactic radiosurgery treatment.

Authors:  Ning Wen; Joshua Kim; Anthony Doemer; Carri Glide-Hurst; Indrin J Chetty; Chang Liu; Eric Laugeman; Ilma Xhaferllari; Akila Kumarasiri; James Victoria; Maria Bellon; Steve Kalkanis; M Salim Siddiqui; Benjamin Movsas
Journal:  Radiother Oncol       Date:  2018-05-25       Impact factor: 6.280

Review 8.  Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues.

Authors:  Arjun Sahgal; Mark Ruschin; Lijun Ma; Wilko Verbakel; David Larson; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

9.  A Systematic Analysis of 2 Monoisocentric Techniques for the Treatment of Multiple Brain Metastases.

Authors:  Ganesh Narayanasamy; Sotirios Stathakis; Alonso N Gutierrez; Evangelos Pappas; Richard Crownover; John R Floyd; Niko Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2016-09-09

10.  A web-based brain metastases segmentation and labeling platform for stereotactic radiosurgery.

Authors:  Zi Yang; Hui Liu; Yan Liu; Strahinja Stojadinovic; Robert Timmerman; Lucien Nedzi; Tu Dan; Zabi Wardak; Weiguo Lu; Xuejun Gu
Journal:  Med Phys       Date:  2020-05-23       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.